Lumish M, Chui MH, Zhou Q, Iasonos A, et al. A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2). Gynecol Oncol 2024;182:75-81.
PMID: 38262242